Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia

BackgroundVentilator-associated pneumonia (VAP) caused by drug-resistant Acinetobacter baumannii is associated with high mortality in critically ill patients. We identified the prognostic factors of 30-day mortality in patients with VAP caused by drug-resistant A. baumannii and compared survival outcomes among multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR) A. baumannii VAP.MethodsA retrospective cohort study was conducted in the Medical Intensive Care Unit at Chiang Mai University Hospital, Thailand. All adult patients diagnosed with A. baumannii VAP between 2005 and 2011 were eligible. Univariable and multivariable Cox’s proportional hazards regression were performed to identify the prognostic factors of 30-day mortality.ResultsA total of 337 patients with microbiologically confirmed A. baumannii VAP were included. The proportion of drug-sensitive (DS), MDR, XDR, and PDR A. baumannii were 9.8%, 21.4%, 65.3%, and 3.6%, respectively. The 30-day mortality rates were 21.2%, 31.9%, 56.8%, and 66.7%, respectively. The independent prognostic factors were SOFA score >5 (hazard ratio (HR) = 3.33, 95% confidence interval (CI) 1.94–5.72, P < 0.001), presence of septic shock (HR = 2.66, 95% CI 1.71–4.12, P < 0.001), Simplified Acute Physiology Score (SAPS) II >45 (HR = 1.58, 95% CI 1.01–2.46, P = 0.045), and inappropriate initial antibiotic treatment (HR = 1.53, 95% CI 1.08–2.20, P = 0.016).ConclusionsDrug-resistant A. baumannii, particularly XDR and PDR, was associated with a high mortality rate. Septic shock, high SAPS II, high SOFA score, and inappropriate initial antibiotic treatment were independent prognostic factors for 30-day mortality.

• Publication year

  2015

• Venue

  Journal of Intensive Care

• Publication date

  2015-03-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s40560-015-0077-4PMID 27408726PMCID 4940762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes.

  2014cited by this paper
• Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.

  2014cited by this paper
• Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review

  2014cited by this paper
• Multidrug Resistance Among Acinetobacter baumannii Isolates from Iran: Changes in Antimicrobial Susceptibility Patterns and Genotypic Profile

  2014cited by this paper
• The Severity of ICU-Acquired Pneumonia

  2013cited by this paper
• Evaluation of semi-quantitative scoring of Gram staining or semi-quantitative culture for the diagnosis of ventilator-associated pneumonia: a retrospective comparison with quantitative culture

  2013cited by this paper
• Journal of Intensive Care: a new journal for all intensive care physicians

  2013cited by this paper
• Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock

  2013cited by this paper
• Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.

  2013cited by this paper
• Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness

  2013cited by this paper
• Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: Nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program

  2012cited by this paper
• Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

  2012cited by this paper
• Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes

  2012cited by this paper
• High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

  2011cited by this paper
• Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis.

  2011cited by this paper
• PREDICTORS OF MORTALITY IN ADULT PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA: A META-ANALYSIS

  2010cited by this paper
• Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital

  2010cited by this paper
• Comparison of Semi-Quantitative Endotracheal Aspirates to Quantitative Non-Bronchoscopic Bronchoalveolar Lavage in Diagnosing Ventilator-Associated Pneumonia

  2009cited by this paper
• International study of the prevalence and outcomes of infection in intensive care units

  2009cited by this paper
• International study of the prevalence and outcomes of infection in intensive care units.

  2009cited by this paper
• The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia.

  2008cited by this paper
• Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria.

  2008cited by this paper
• Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

  2008cited by this paper
• Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia

  2008cited by this paper
• Acinetobacter baumannii: a universal threat to public health?

  2008cited by this paper
• Mortality Rates Associated With Multidrug-Resistant Acinetobacter baumannii Infection in Surgical Intensive Care Units

  2008cited by this paper
• Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

  2008cited by this paper
• Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.

  2007cited by this paper
• High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

  2007cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• Incidence, risk factors, and outcome of ventilator-associated pneumonia.

  2006cited by this paper
• Nosocomial Infections Caused by Acinetobacter baumannii A Major Threat Worldwide

  2006cited by this paper
• Risk factors of mortality for nosocomial pneumonia: importance of initial anti‐microbial therapy

  2005cited by this paper
• Epidemiology and outcomes of ventilator-associated pneumonia in a large US database.

  2002cited by this paper
• Survival of Acinetobacter baumannii on dry surfaces

  1997cited by this paper

• Single-ascending and multiple-ascending dose study of the pharmacokinetics, safety, and tolerability of BV100 (rifabutin for infusion) in healthy volunteers

  2026cites this paper
• Mortality in Ventilator‐Associated Tracheobronchitis and Pneumonia in Oncology Patients: The Impact of Microbiological Aspects

  2026influential citation
• A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections

  2025cites this paper
• Characteristics of ventilator-associated pneumonia due to Gram-negative bacteria in the intensive care unit: A single-center experience

  2025cites this paper
• The intricacies of Acinetobacter baumannii: a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications

  2025cites this paper
• Ampicillin potentiation ability of PLGA encapsulated Acorus calamus clarified crude extract targeting Acinetobacter baumannii

  2025cites this paper
• Short-course antibiotic strategies for ventilator-associated pneumonia

  2025cites this paper
• Standard- versus high-dose tigecycline in pneumonia due to carbapenem-resistant Acinetobacter baumannii.

  2025cites this paper
• Prognostic Indicators of Carbapenem‐Resistant Acinetobacter baumannii Infection: A Meta‐Analysis and Systematic Review

  2025cites this paper
• ESKAPE pathogens and associated quorum sensing systems: New targets for novel antimicrobials development

  2024cites this paper
• A chronic murine model of pulmonary Acinetobacter baumannii infection enabling the investigation of late virulence factors, long-term antibiotic treatments, and polymicrobial infections

  2024cites this paper
• Transcriptomic analysis reveals zinc-mediated virulence and pathogenicity in multidrug-resistant Acinetobacter baumannii.

  2024cites this paper
• Cross-talk of MLST and transcriptome unveiling antibiotic resistance mechanism of carbapenem resistance Acinetobacter baumannii clinical strains isolated in Guiyang, China

  2024cites this paper
• Outcome of Acinetobacter baumannii Ventilator Associated Pneumonia in Upper Egypt: does the resistance profile play a role?

  2024cites this paper
• Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of tigecycline for post‑neurosurgical intracranial infections due to MDR/XDR Acinetobacter baumannii: A retrospective cohort study.

  2024cites this paper
• Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic

  2023cites this paper
• Prevalence of Acinetobacter baumannii with multiple drug resistance isolated from patients with ventilator-associated pneumonia from 2010 to 2020 in the world: a systematic review and meta-analysis

  2023cites this paper
• Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii

  2023cites this paper
• Quantitative and Qualitative Determination of Biofilm Formation Pattern in Multidrug Resistance Acinetobacter baumannii in Correlation with COVID-19 and Respiratory Infected Patients

  2023cites this paper
• Acinetobacter cavitations in COVID-19 interstitial pneumonia: a case report and review of the literature

  2023cites this paper
• Feature architecture aware phylogenetic profiling indicates a functional diversification of type IVa pili in the nosocomial pathogen Acinetobacter baumannii

  2023cites this paper
• Hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19

  2023cites this paper
• A two-year retrospective study of multidrug-resistant Acinetobacter baumannii respiratory infections in critically Ill patients: Clinical and microbiological findings.

  2023cites this paper
• Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study

  2022cites this paper
• Outer Membrane Vesicle-Coated Nanoparticle Vaccine Protects Against Acinetobacter baumannii Pneumonia and Sepsis.

  2022cites this paper
• Acinetobacter baumannii pneumonia increases surfactant proteins SP-A, SP-B, and SP-D levels, while decreasing SP-C level in bronchoalveolar lavage in rats

  2022cites this paper
• InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis

  2022cites this paper
• Fitness Costs of Tigecycline Resistance in Acinetobacter baumannii and the Resistance Mechanism Revealed by a Transposon Mutation Library

  2022cites this paper
• Clinical Features and Outcomes of Monobacterial and Polybacterial Episodes of Ventilator-Associated Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii

  2022cites this paper
• An Outer Membrane Protein YiaD Contributes to Adaptive Resistance of Meropenem in Acinetobacter baumannii

  2022cites this paper
• Risk Factors for Mortality in Children with Hospital-Acquired Pneumonia in Dr. Soetomo General Hospital Surabaya

  2021cites this paper
• Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Predictors of Acute Kidney Injury and 28-Day Mortality in Carbapenem-Resistant Acinetobacter baumannii Complex Bacteremia

  2021cites this paper
• Prognostic biomarkers in predicting mortality in respiratory patients with ventilator-associated pneumonia

  2021cites this paper
• Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study

  2021cites this paper
• Evaluation of Acute Renal Failure After Acinetobacter Baumannii-based Ventilator-associated Event: A Retrospective Cohort Study

  2021cites this paper
• Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii

  2021cites this paper
• Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR Acinetobacter baumannii: In silico, in vitro and in vivo Studies

  2021cites this paper
• Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It

  2021cites this paper
• Identification of Two Variants of Acinetobacter baumannii Strain ATCC 17978 with Distinct Genotypes and Phenotypes

  2021cites this paper
• Iron-Rich Conditions Induce OmpA and Virulence Changes of Acinetobacter baumannii

  2021cites this paper
• Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy

  2021cites this paper
• Replication initiator proteins of Acinetobacter baumannii plasmids: An update note.

  2021cites this paper
• Impact of Extended and Restricted Antibiotic Deescalation on Mortality

  2021cites this paper
• Acinetobacter Baumannii – Virulence Factors and Epidemiology of Infections

  2021cites this paper
• Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics

  2020cites this paper
• Epidemiology and the Risk Factors for Mortality in Ventilator-Associated Pneumonia

  2020cites this paper
• Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients.

  2020cites this paper
• Pathogenesis-Targeted Preventive Strategies for Multidrug Resistant Ventilator-Associated Pneumonia: A Narrative Review

  2020cites this paper
• Acinetobacter baumannii: Infections and Drug Resistance

  2020cites this paper
• Quorum‐sensing system in Acinetobacter baumannii: a potential target for new drug development

  2020influential citation
• Comparison of Cefepime-Cefpirome and Carbapenem Therapy for Acinetobacter Bloodstream Infection in a Multicenter Study

  2020cites this paper
• Crucial Role of the Accessory Genome in the Evolutionary Trajectory of Acinetobacter baumannii Global Clone 1

  2020cites this paper
• Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection

  2020cites this paper
• New Delhi metallo-β-lactamase-producing Acinetobacter isolates among late-onset VAP patients: multidrug-resistant pathogen and poor outcome

  2019cites this paper
• Risk Factors for Mortality Due to Ventilator-Associated Pneumonia in a Chinese Hospital: A Retrospective Study

  2019cites this paper
• Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options.

  2019cites this paper
• Human Pleural Fluid Elicits Pyruvate and Phenylalanine Metabolism in Acinetobacter baumannii to Enhance Cytotoxicity and Immune Evasion

  2019cites this paper
• The Effectiveness of Oral Care Guideline Implementation on Oral Health Status in Critically Ill Patients

  2019influential citation
• The current epidemiological landscape of ventilator-associated pneumonia in the intensive care unit: a multicenter prospective observational study in China—study critique, ventilator-associated pneumonia incidence rates, and pathogen distribution

  2019cites this paper
• Acinetobacter etiology respiratory tract infections associated with mechanical ventilation: what impacts on the prognosis? A retrospective cohort study

  2019cites this paper
• Ventilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality

  2019influential citation
• Factors Associated with Mortality in Immunocompetent Patients with Hospital-acquired Pneumonia

  2019influential citation
• Risk factors for Pseudomonas aeruginosa infections in Asia-Pacific and consequences of inappropriate initial antimicrobial therapy: A systematic literature review and meta-analysis.

  2018cites this paper
• Risk factors for mortality in ICU patients with Acinetobacter baumannii ventilator-associated pneumonia: impact of bacterial cytotoxicity.

  2018cites this paper
• Estimating the burden of antimicrobial resistance: a systematic literature review

  2018cites this paper
• A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii

  2018cites this paper
• Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria

  2018cites this paper
• Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis

  2017cites this paper
• Analysis of Resistance Pattern of Acinetobacter Species in a Tertiary Care Hospital: A Retrospective Study

  2017cites this paper
• Etiology and resistance patterns of bacteria causing ventilator-associated pneumonia in a respiratory intensive care unit

  2017cites this paper
• Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis

  2017cites this paper
• The outbreak of Acinetobacter baumannii producing OXA-23 and OXA-51 type carbapenemases in a state hospital

  2016influential citation
• Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.

  2015cites this paper